Company Filing History:
3 out of 870 
2 out of 157 
1 out of 1,746 
Years Active: 2007-2015
Title: The Innovations of Xavier Cayla
Introduction
Xavier Cayla, an accomplished inventor based in Rochecorbon, France, has made significant contributions to the field of biotechnology with a focus on peptides and their applications in medicine. With a robust portfolio of five patents, Cayla continues to push the boundaries of scientific research and innovation.
Latest Patents
Among his latest innovations, Cayla has developed pro-apoptotic peptides that serve as agents for inhibiting cell proliferation and treating tumors. This advancement highlights the potential for targeted therapies in oncology. Furthermore, he has unveiled novel synthetic or natural peptides that bind with protein phosphatase 2A, which are instrumental in treating viral or parasitic infections and various tumors. Notably, these peptides, which consist of fewer than 30 amino acids, have shown specific binding capabilities to a type 2A protein phosphatase holoenzyme or its subunits, paving the way for new therapeutic methods and identification techniques.
Career Highlights
Cayla's career is marked by his association with prestigious institutions such as the Institut Pasteur and Université Pierre et Marie Curie (Paris 6). His work in these esteemed organizations has cemented his reputation as an innovative thinker and a leading figure in the field of peptide research.
Collaborations
Throughout his career, Cayla has collaborated with other talented scientists, including Alphonse Garcia and Angelita Rebollo. These collaborations have enabled him to expand his research efforts and contribute meaningfully to the scientific community.
Conclusion
Xavier Cayla's innovative contributions to the field of biotechnology through his patents demonstrate his commitment to improving health outcomes. His ongoing research and collaboration with other experts continue to hold promise for advancements in medical treatments and therapies. As he progresses in his career, the scientific community eagerly anticipates his future breakthroughs.